{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001742927","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","summary":"Reviva Pharmaceuticals Holdings, Inc. is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for central nervous system, inflammatory, and cardiometabolic diseases. Its pipeline includes two drug candidates: brilaroxazine (RP5063), a multimodal serotonin, dopamine, and nicotinic receptor modulator in clinical development for schizophrenia, bipolar disorder, MDD, ADHD, PAH, and IPF; and RP1208, in preclinical stage. Both are new chemical entities discovered in-house with composition of matter patents granted in the U.S., Europe, and other countries.","people":[],"products":[{"name":"Brilaroxazine (RP5063)","type":"platform","description":"Novel multimodal serotonin, dopamine, and nicotinic receptor modulator in clinical development for schizophrenia, bipolar disorder, MDD, ADHD, PAH, IPF, and other neuropsychiatric and respiratory indications."},{"name":"RP1208","type":"platform","description":"Preclinical-stage new chemical entity discovered in-house with composition of matter patents granted in the U.S., Europe, and other countries."}],"partnerships":[{"partner_name":"B. Riley Securities, Inc.","partnership_type":"strategic","description":"Serves as agent under the May 2025 ATM Sales Agreement for at-the-market common stock offerings up to $50 million.","start_date":null},{"partner_name":"Alliance Global Partners","partnership_type":"strategic","description":"Serves as co-agent under the May 2025 ATM Sales Agreement for at-the-market common stock offerings up to $50 million.","start_date":null}],"affiliations":[],"origin":{"leaf":"13bb9fdb6fef2859ff5e3901475a3eec8182203c9f1ec6a846c223b6d78c8f8d","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"7bacc610ff9720238adc27fee3281e23c875177afd650c2f64c37be40ea45621","parent":"7f377bcf374ef16df1eb246338a87dc9fb9b7670c1f0603bc0a3f320589ee365","source":"0001437749-26-010126","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":91,"hourly_limit":500,"remaining":409,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}